Literature DB >> 6683794

Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.

S C Schold, C E Rawlings, S H Bigner, D D Bigner.   

Abstract

Tumors derived from the established human glioma cell line D-54 MG were transplanted intracerebrally into athymic "nude" mice. All control mice developed tumors in the brain after the transplantation of 10(5) cells and died within 30 days. Tumor was purely intracerebral in the presymptomatic stages, including the time of drug treatment. The injection of serial cell dilutions reduced the tumor incidence and prolonged survival. Procarbazine (PCB), 1,3-bis(2-chloroethyl)-1-nitrosourea, diaziquone (aziridinylbenzoquinone), and cis-platinum each produced statistically significant increases in survival when administered on Day 10 after transplantation, and PCB alone cured most of the animals. These results extend the characterization of the human glioma line D-54 MG and confirm the value of the athymic mouse for the testing of chemotherapeutic agents of interest in brain tumor therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683794     DOI: 10.1227/00006123-198306000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

1.  Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model.

Authors:  L White; K Sterling-Levis; R Fisher; V Tobias
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

2.  A new rat brain tumor model: glioma disseminated via the cerebral spinal fluid pathways.

Authors:  A B Rewers; E S Redgate; M Deutsch; E R Fisher; S S Boggs
Journal:  J Neurooncol       Date:  1990-06       Impact factor: 4.130

Review 3.  What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.

Authors:  S Amarasingh; M R Macleod; I R Whittle
Journal:  J Neurooncol       Date:  2008-09-24       Impact factor: 4.130

4.  Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015.

Authors:  William J Bodell; Donald D Giannini; Saira Singh; Dennis Pietronigro; Victor A Levin
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

5.  Intracerebral chemotherapy in the 9L rat brain tumor model.

Authors:  B F Kimler; C Liu; R G Evans; R A Morantz
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

6.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.

Authors:  P A Barnett; S Roman-Goldstein; F Ramsey; C I McCormick; G Sexton; J Szumowski; E A Neuwelt
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

8.  Current brain tumour models with particular consideration of the transplantation techniques. Outline of literature and personal preliminary results.

Authors:  B Rama; O Spoerri; M Holzgraefe; H D Mennel
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

9.  The chemotherapeutic response of a murine (VM) model of human glioma.

Authors:  R Bradford; J L Darling; D G Thomas
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.